Menu
Back to Journals » Drug Design, Development and Therapy » Volume 15
Original Research
No Relevant Pharmacokinetic Drug–Drug Interaction Between the Sodium-Glucose Co-Transporter-2 Inhibitor Empagliflozin and Lobeglitazone, a Peroxisome Proliferator-Activated Receptor-γ Agonist, in Healthy Subjects
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 5,062 | Dovepress* | 4,537+ | 564 | 5,101 | |
| PubMed Central* | 525 | 170 | 695 | ||
| Totals | 5,062 | 734 | 5,796 | ||
| *Since 28 April 2021 | |||||
View citations on PubMed and Google Scholar